Sens. Target Small Drugmaker Over 300-Fold Price Hike
U.S. senators targeted a small drugmaker on Tuesday over a 300-fold spike in the price of a rare-disease medicine, calling the increase "unacceptable" in light of the medicine's importance and long...To view the full article, register now.
Already a subscriber? Click here to view full article